NEW YORK (GenomeWeb) – Novacyt announced today that its molecular testing division, Primerdesign, has inked an exclusive supply agreement with Genesis Diagnostics.

Primerdesign will develop and supply 384-well plate molecular assay panels in the areas of respiratory, women's health, sexually transmitted, wound, and urinary tract infections to Genesis to use in its Langhorne, Pennsylvania-based clinical service laboratory.